Orbimed Advisors - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$826,781
-11.2%
802,7000.0%0.02%
+5.9%
Q2 2023$931,132
-23.2%
802,7000.0%0.02%
-29.2%
Q1 2023$1,212,077
-74.4%
802,700
-28.5%
0.02%
-72.7%
Q3 2022$4,739,000
-81.2%
1,123,000
-5.8%
0.09%
-60.2%
Q4 2020$25,225,000
+42.8%
1,191,8460.0%0.22%
-0.5%
Q3 2020$17,663,000
+81.8%
1,191,846
+80.5%
0.22%
+62.0%
Q2 2020$9,715,000
+54.0%
660,420
+22.9%
0.14%
+29.2%
Q1 2020$6,309,000
-75.9%
537,420
-49.7%
0.11%
-73.8%
Q1 2019$26,126,000
-28.1%
1,069,000
-23.7%
0.40%
-39.9%
Q4 2018$36,324,000
-24.2%
1,400,300
-7.5%
0.67%
+16.5%
Q3 2018$47,934,000
-6.2%
1,514,500
+15.2%
0.58%
-5.3%
Q2 2018$51,092,000
+62.4%
1,315,100
+15.4%
0.61%
+56.2%
Q1 2018$31,458,000
+167.4%
1,139,800
+75.4%
0.39%
+161.7%
Q4 2017$11,765,000
+12.1%
650,0000.0%0.15%
+49.0%
Q3 2017$10,498,000
+16.6%
650,0000.0%0.10%
+6.4%
Q2 2017$9,003,000
-7.7%
650,0000.0%0.09%
-15.3%
Q1 2017$9,750,000650,0000.11%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders